Hepatitis B virus is implicated in the development of hepatocellular caracinoma. No oncogenes have been identified within the viral genome. Furthermore, it frequently fragments after integration into the hepatocyte genome. Simultaneous investigations of hepatitis B virus integration patterns and genetic changes in precancerous tissues are important to understand the role played by hepatitis B virus integration in hepatocellular caracinoma.
Method
We used a combination approach of dual characterization of highly polymorphic loci and the change in hepatitis B virus-DNA integration pattern. Large regenerative nodules were dissected from 6 explanted hepatitis B virus infected cirrhotic livers. Nodules within each liver segment were schematically mapped and histopathologically analyzed. Genomic DNA from each nodule was analyzed for hepatitis B virus integration and the genetic stability of 12 microsatellite loci including D3S2321, D8S1022, D17S1159, D4S2281, D5S1/2, D16S675, D16S685, D16S490, D16S526, D16S673, D16S677 and D16S690.
Results
Data from different liver segments revealed few viral integrations and average allele loss. The most exciting results came from a segment containing a set of clonally and spatially related nodules having similar histologic features, a progressive lineage of allele loss, HBV integration and loss of integration.
Conclusions
This model portrait, a scenario of genetic events that precede tumor formation where the acquisition and loss of hepatitis B virus integrations in clonally related regenerative nodules, might explain how the virus acts as a hit-and-run mutagen.
ShafritzD.A., ShouvalD., ShermanH.I., HadziyannisS.J., KewM.C.: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med, 305: 1067–1073, 1981.
2.
SzaboE., PaskaC., Kaposi NovakP., SchaffZ., KissA.: Similarities and differences in hepatitis B and C virus-induced hepatocarcinogenesis. Pathol Oncol Res, 10: 5–11, 2004.
3.
TaborE., Di BiscegliA.M., PurcellR.H.: Etiology, pathology and treatment of hepatocellular carcinoma in North America.The Woodlands, TX: Portfolio, 107–117, 1991.
4.
TrichopoulosD., DayN.E., KaklamaniE., TzonouA., MunozN., ZavitsanosX., KoumantakiY., TrichopoulouA.: Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer, 39: 45–49, 1991.
5.
WangJ., ZindyF., ChenivesseX., LamasE., HengleinB., BrechotC.: Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinonoma. Oncogene, 7: 1653–1656, 1992.
6.
De TheH., MarchioA., TiollaisP., DejeanA.: A novel thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature, 330: 667–670, 1987.
7.
GracefE., CasselmannW.H., WellsJ., KoshyR.: Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line. Oncogene, 3: 537–540, 1987.
8.
GozuacikD., MurakamiY., SaigoK., ChamiM., MugneirC., LagorceD., OkanouneT., UrashimaT., BrechotC., BrechotP.P.: Identification of human cancer-related genes by naturally occurring hepatitis B virus DNA targeting. Oncogene, 20: 6233–6240, 2001.
9.
BuenedaM.A.: Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res, 59: 167–226, 1992.
10.
RoglerC.E.: Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepandavirus infection. Curr Top Microbiol Immuni, 168: 103–140, 1991.
11.
HinoO., ShowsT.B., RoglerC.E.: Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation. Proc Natl Acad Sci USA, 83: 8338–8342, 1986.
12.
PineauP., MarchioA., MatteiM.G., KimW.H., YounJ.Y., TiollaisP., DeajeanA.: Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma. J Gen Virol, 79: 591–600, 1998.
13.
NagayaT., NakamuraT., TokinoT., TsurimotoT., ImaiM., MayumiT., KaminoK., YamamuraK., MatsubaraK.: The mode of integration of hepatitis B virus DNA in chromosomes of human hepatocellular carcinoma. Genes Dev, 1: 773–782, 1987.
HsuH.C., ChiouT.J., ChenJ.Y., LeeC.S., PengP.H.: Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology, 13: 923–928, 1991.
16.
ShihS., JensenA.D., RoglerC.E.: Loss and acquisition of Duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells. J Virol, 70: 2000–2007, 1996.
17.
RoglerC.E.: Hepatitis B viruses: a triple threat for malignant transformation of hepatocytes. Meth Mol Med, 95: 327–337, 2004.
18.
NikolausB., StaffordD.W.: A general method for isolation of high molecular weight DNA from eukaryotes. Nucl Acid Res, 3: 2303–2308, 1976.
19.
OrnataM., EhataT., YokosukaO., HosodaK., OhtoO.: Mutations in the precore region of hepatitis B virus in patients with fulminant and severe hepatitis. New Eng J Med, 234: 1699–1704, 1991.
20.
SaikiR.K., GelfandD.H., StoffelS., ScharfS.J., HiguchiR., HornG.T., MullisK.B., ErlichH.A.: Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239: 487–491, 1988.
21.
FeinbergA.P., VogelsteinB.: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem, 132: 6–13, 1983.
22.
SouthernE.M.: Detection of specific sequences among DNA fragments separated by gel electerophoresis. J Mol Biol, 98: 503–517, 1975.
23.
WhiteV.A., McNeilB.K., HorsmanD.E.: Acquired homozygosity (isodisomy) of chromosome 3 in melanoma. Cancer Genet Cytogenet, 102: 41–45, 1998.
24.
RenE.C.: Hepatitis B virus and hepatocellular carcinoma. Ann Acad Med Singapore, 25: 17–21, 1996.
25.
TsudaH., OdaT., SakamotoM., HirohashiS.: Different patterns of chromosomal allele loss in multiple hepatocellular carcinomas as evidence by their multifocal origin. Cancer Res, 52: 1504–1509, 1992.
26.
SheuJ.C., HuangG.T., ChouH.C., LeeP.H., WANGJ.T., LeeH.S., ChenD.S.: Multiple hepatocellular carcinoma at the early stage have different colonality. Gastroenterology, 105: 1471–1476, 1993.
27.
KonishiM., YanoshitaR.K., TanokaK., SatoC., TsurutaK., MedaY., TanakaS., NakamuraY., HattoriN., MiyakiM.: Genetic changes and histopathological grades in human hepatocellular carcinoms. Jpn J Cancer Res, 84: 893–899, 1993.
28.
KurrokiT., FujiwaraY., TsuchiyaE., NakamoriS., ImaokaS., KanematsuT., NakamuraY.: Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosome Cancer, 13: 163–167, 1995.
29.
YumamotoY., HanafusaT., HadaH., MoritaT., OacuchiS., ShinjiN., MitaniT., MamayaK., KoideN., TsujiT.: Loss of heterozygosity and analysis of mutation of. P53 in hepatocellular carcinoma. J Gastroentrol Hepatol, 10: 179–185, 1995.
30.
VogelesteinB., FearonE.R.: Frequent allelic loss on chromosome 16 in hepatocellular carcinoma. Biochem Biophysica Acta, 458: 283–321, 1990.
31.
DixB.R., ObbinsP.D., SpanoloD.V., PadovanG.L., HouseK., IacopettaB.J.: Clonal analysis of colorectal tumors using K-ras and P53 gene mutations as markers. Diagn Mol Pathol, 4: 261–265, 1995.
32.
PiaoZ., ParkY.N., ParkC.: Clonality of large regenerative nodules in liver cirrhosis. Liver, 17: 251–256, 1997.
33.
OchaiT., UrataY., YamanoT., YamagishiH., AshiharaT.: Clonal expression in evolution of chronic hepatitis to hepatocellular carcinoma as seen at X-chromosome locus. Hepatology, 31: 615–621, 2000.
34.
AiharaT., NoguchiS., SasakiY., NakanoH., ImaokaS.: Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroentrology, 107: 1805–1811, 1994.
35.
TheinS.L., JeffreysA.J., GooiH.C., CotterF., FlintJ., O'ConnorN.T., WeatherallD.J., WainscoatJ.S.: Detection of somatic changes in human cancer DNA by DNA fingerprinting analysis. Br J Cancer, 55: 353–356, 1979.
36.
TsudaH., ZhngW., ShimosatoY., YokotaJ., TeradaM., SugimuraT., MiyamuraT., HirrhashiS.: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA, 87: 6791–6794, 1990.
37.
NishidaN., NishimuraT., ItoT., KomedaT., FukudaY., NakaoK.: Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol, 18: 897–909, 2003.
38.
HirohashiF., DidhuM.K., RashidbaigiA., LiaoM., TestaD.: Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer, 64: 1083–1087, 1990.
